{
    "organizations": [],
    "uuid": "ef88bc96305e3744d8602360c0a7c79f379b4d59",
    "author": "",
    "url": "https://www.reuters.com/article/brief-spectrum-pharmaceuticals-enters-in/brief-spectrum-pharmaceuticals-enters-into-a-next-generation-sequencing-companion-diagnostic-partnership-with-thermo-fisher-scientific-idUSFWN1S806Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 11:36 AM / Updated 5 minutes ago BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific Reuters Staff\nMay 1 (Reuters) - Spectrum Pharmaceuticals Inc:\n* SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC\n* SPECTRUM PHARMACEUTICALS INC - ENTERED INTO AN AGREEMENT WITH THERMO FISHER SCIENTIFIC\n* SPECTRUM PHARMACEUTICALS - AGREEMENT TO LEVERAGE ONCOMINE DX TARGET TEST AS COMPANION DIAGNOSTIC FOR SPECTRUMâ€™S NOVEL PAN-HER INHIBITOR POZIOTINIB Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-05-01T14:35:00.000+03:00",
    "crawled": "2018-05-01T14:56:57.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "enters",
        "sequencing",
        "companion",
        "diagnostic",
        "partnership",
        "thermo",
        "fisher",
        "scientific",
        "reuters",
        "staff",
        "may",
        "reuters",
        "spectrum",
        "pharmaceutical",
        "inc",
        "spectrum",
        "pharmaceutical",
        "enters",
        "sequencing",
        "companion",
        "diagnostic",
        "partnership",
        "thermo",
        "fisher",
        "scientific",
        "spectrum",
        "pharmaceutical",
        "inc",
        "entered",
        "agreement",
        "thermo",
        "fisher",
        "scientific",
        "spectrum",
        "pharmaceutical",
        "agreement",
        "leverage",
        "oncomine",
        "dx",
        "target",
        "test",
        "companion",
        "diagnostic",
        "spectrum",
        "novel",
        "inhibitor",
        "poziotinib",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}